As of 2024-12-14, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 5.07 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.91 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is -73.2%.
The range of the Relative Valuation is 3.81 - 7.58 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 34.4x | 25.8x |
| Forward P/E multiples | 19.4x - 21.0x | 20.2x |
| Fair Price | 3.81 - 7.58 | 5.07 |
| Upside | -79.8% - -59.9% | -73.2% |
| Date | P/E |
| 2024-12-13 | 85.85 |
| 2024-12-12 | 86.31 |
| 2024-12-11 | 88.67 |
| 2024-12-10 | 93.34 |
| 2024-12-09 | 105.15 |
| 2024-12-06 | 115.54 |
| 2024-12-05 | 118.18 |
| 2024-12-04 | 120.27 |
| 2024-12-03 | 122.81 |
| 2024-12-02 | 122.81 |
| 2024-11-29 | 125.35 |
| 2024-11-27 | 126.58 |
| 2024-11-26 | 121.22 |
| 2024-11-25 | 118.45 |
| 2024-11-22 | 118.22 |
| 2024-11-21 | 113.68 |
| 2024-11-20 | 110.37 |
| 2024-11-19 | 108.55 |
| 2024-11-18 | 103.24 |
| 2024-11-15 | 109.42 |
| 2024-11-14 | 124.67 |
| 2024-11-13 | 124.44 |
| 2024-11-12 | 123.58 |
| 2024-11-11 | 113.27 |
| 2024-11-08 | 100.20 |
| 2024-11-07 | 70.10 |
| 2024-11-06 | 68.46 |
| 2024-11-05 | 65.83 |
| 2024-11-04 | 63.88 |
| 2024-11-01 | 64.47 |
| 2024-10-31 | 61.88 |
| 2024-10-30 | 64.79 |
| 2024-10-29 | 65.10 |
| 2024-10-28 | 65.92 |
| 2024-10-25 | 64.29 |
| 2024-10-24 | 65.51 |
| 2024-10-23 | 66.24 |
| 2024-10-22 | 67.47 |
| 2024-10-21 | 67.24 |
| 2024-10-18 | 68.60 |
| 2024-10-17 | 68.74 |
| 2024-10-16 | 70.96 |
| 2024-10-15 | 69.46 |
| 2024-10-14 | 68.65 |
| 2024-10-11 | 70.05 |
| 2024-10-10 | 69.15 |
| 2024-10-09 | 68.60 |
| 2024-10-08 | 71.28 |
| 2024-10-07 | 69.87 |
| 2024-10-04 | 72.82 |